American Board of Clinical Metal Toxicology (ABCMT) was established in 1982.
It originally was the American Board of Chelation Therapy.
purpose of this Board is to:
define and establish the qualifications to be required of licensed
physicians and equivalents for American Certification as Board Certified
persons in the field of Clinical Metal Toxicology and any other field that
may be assumed by this Board.
require all applicants to submit evidence that they meet all established
requirements for licensed physicians, or their equivalents, particularly
with regard to ordering and supervising the administering of intravenous
authorize and approve training seminars in accordance with the bylaws,
necessary for Board Certification in Clinical Metal Toxicology.
conduct examinations in conformity with the bylaws of the Board.
issue documents of Board Certification in American Clinical Metal
Toxicology to each of those candidates who are qualified.
recommend revocation of Board Certification for cause.
and present day perspective:
Alfred Werner, a Swiss chemist discovered metal ligand binding in the late
1800s. He was awarded the Nobel Prize for Chemistry for this discovery in
1913. Two American physicians, Drs. Drew and Morgan, used the Greek word
chelae, describing a claw such as in a lobster or crab, and renamed the metal
ligand binding process as chelation therapy. It was only developed and used in
medicine when it was found that metals could be associated with toxic health
problems and became popular in the 1950s to detoxify lead.
March 21, 2004
, Gina Kolata)
recently stated that there is no long term benefit from coronary artery bypass
surgery. The Wall Street Journal (
December 17, 2004
, page 1, Pottinger,
Stecklow, Fialka) comments on the mercury global pollution caused by
growth, particularly the use of coal for electricity generation. During the
past three years multiple articles have appeared in many peered reviewed
medical journals showing the association of toxic metals with all vascular
diseases and their sequellae as well as macular degeneration and even cancers.
During the years that heart surgery gained its place as the preferred
treatment of atherosclerotic heart disease, a small group of physicians
continued to use the process of metal detoxification with seemingly positive
clinical improvement in their patients.
Clinical observations were made in heart patients with angina who improved
clinically as the lead was detoxified. Chelation therapy then became popular
from the mid 1950s to the mid 1960s as one form of treatment for heart
disease. Technology and science replaced this simplistic method for treating
heart problems with the advent of heart surgery. Now after almost 40 years of
perfecting heart surgery a re-evaluation of that procedure is currently going
The New York Times, (
This cadre of physicians taught and tested the competence of their fellow
physicians to safely administer this treatment. Now with the explosive science
in metals toxicology and the world wide concern of toxic metals in our
environment and food chain, renewed scientific attention is discovering the
true role of toxic metals in health and disease.
The ABCMT is the only professional organization in the
continuously tested and certified physicians in clinical metal toxicology.
With the new scientific knowledge the testing and certifying programs will be
updated and expanded to remain current.
Liaison is maintained with the International Board of Clinical Metal
Toxicology (IBCMT) to bring as much uniformity as possible to the world wide
scientific and medical implications of toxic metals, health and their role in
diseases. ABCMT will continue to safeguard the public by testing physician
knowledge and competency to safely and professionally detoxify toxic metals.
Medicare is paying for in office intravenous toxic metals detoxification in
the District of Columbia,
and the Indian
Health Service. As new data is collected, collated and analyzed, it is hoped
that toxic metals will be recognized as THE CORRECTIBLE RISK FACTOR in many of
the diseases of aging.